Novant Health Newsroom

Press Releases

Healthy Headlines

These assets may be used for media coverage. Contact Novant Health PR for more information.

How to navigate the fast-changing world of weight-loss drugs.

Given that 73.6% of American adults are overweight or have obesity, there’s a lot of interest in weight-loss drugs now. Another drug initially intended to treat Type 2 diabetes has recently been approved to treat obesity. A Novant Health expert answered all our pressing questions about Zepbound and similar drugs.

Media Cart

Media Cart is empty